Medtronic AAA advocacy
This article was originally published in The Gray Sheet
Executive Summary
Firm unveils "Find the AAAnswers" campaign, designed to draw attention to prevention and treatment of abdominal aortic aneurysms, at a New York City press conference Sept. 22. Medtronic's AneurRx AAAdvantage and Talent stent grafts are used in endovascular repair of AAA. The campaign, sponsored by Medtronic and supported by the Society for Vascular Surgeons, the American College of Preventive Medicine and the Society for Vascular Ultrasound, will include education and screening events, an interactive web portal (FindtheAAAnswers.org) and public service announcements. A one-time Medicare AAA ultrasound screening benefit for at-risk beneficiaries took effect in 2007, but screening rates have not climbed as much as hoped. At-risk patients are defined by Medicare as male smokers or men and women with a family history of the condition. AAA advocates are pushing to expand coverage beyond the one-time screen, which must occur within 12 months of enrollment, as part of health reform legislation (1"The Gray Sheet" Aug. 10, 2009)
You may also be interested in...
House Health Reform Amendments Round-Up: AAA Screening Report, No IMAC
Amendments to ban reduced payments for pain treatments and make screenings for aneurysms a priority are just two provisions added to a health reform bill during the House Energy and Commerce Committee's marathon mark-up sessions July 30 and 31
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.